Align Technology, Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Joseph Hogan
- Full Time Employees
- 21,200
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 410 North Scottsdale Road Tempe AZ United States of America 85288
- IPO Date
- Jan 30, 2001
- CIK
- 0001097149
- Website
- aligntech.com
- Similar Companies
- Business
- Align Technology, Inc. (Nasdaq: ALGN) manufactures and markets a comprehensive portfolio of clear aligner systems, intraoral scanners, and digital dentistry solutions for orthodontic and restorative treatments worldwide. The company offers the Invisalign System, including Invisalign Comprehensive, Teen, First, Go, and Moderate packages with proprietary SmartTrack material, SmartForce features, and ClinCheck treatment planning software; Vivera retainers; the iTero family of intraoral scanners such as iTero Element Plus Series, Element 5D, and Element 2 with advanced imaging, TimeLapse technology, and integration for restorative workflows; the Align Digital Platform encompassing Exocad CAD/CAM software for dental labs and practices; and the Invisalign Palatal Expander System, a direct 3D-printed orthodontic device for maxillary expansion in growing patients. Founded in 1997 and headquartered in Tempe, Arizona, with manufacturing in Mexico, Israel, and China, treatment planning in Costa Rica, and operations across more than 100 markets including the U.S., EMEA, Asia Pacific, and Latin America, Align serves orthodontists, general dentists, and over 271,000 trained doctors treating approximately 20 million patients to date. In January 2024, Align acquired Cubicure GmbH for approximately €79 million to enhance direct 3D printing capabilities for scalable production of custom appliances like the Invisalign Palatal Expander, which launched commercially in select markets including Canada, Australia, and EMEA in 2024-2025 pending regulatory approvals; the company continues expanding the Invisalign portfolio with innovations in teen and pediatric treatments while reporting Q3 2025 revenues of $995.7 million.
Align Technology to Announce Second Quarter 2026 Results on July 29, 2026
Align Technology Statement on European Commission Proceeding
ALGN or SAUHY: Which Is the Better Value Stock Right Now?
Here's Why Align Technology (ALGN) is a Strong Value Stock
Here's Why Align Technology (ALGN) is a Strong Momentum Stock
Align Technology Announces Board Leadership Transition. C. Raymond Larkin, Jr. to Retire as Chairman and Kevin Conroy to be Appointed Chairman Effective July 1, 2026
Align Technology (ALGN) Just Overtook the 50-Day Moving Average
Align Technology, Inc. (ALGN) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Align Technology CFO: Global Growth, DSOs Offset North America Demand Pressure
Align Technology, Inc. (ALGN) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Align Technology, Inc. (ALGN) Presents at 46th Annual William Blair Growth Stock Conference Prepared Remarks Transcript
Align Technology Pitches AI-Powered Digital Dentistry Platform Beyond Invisalign
Align Technology Awards Funding to Universities Worldwide for Advancing Orthodontic and Dental Research
Align Technology (ALGN) Down 1.6% Since Last Earnings Report: Can It Rebound?
Align Technology Highlights New Invisalign Solutions, Financing and Global Growth
Align Technology, Inc. (ALGN) Presents at Stifel Jaws & Paws Conference 2026 Transcript
Can CAH's Surging Other Growth Businesses Become Its Next Profit Engine?
Align Technology Expands Global Operations With Plans for New Multi-Million Dollar Manufacturing Facility in Hyderabad, India
Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year?
Align Technology Hosts 400 Doctors at 2026 Invisalign® EMEA Ortho Summit Featuring Digital Orthodontic Solutions Focused on Clinical Indications and Upcoming Align Innovations